Marco Rubio says he 'would expect India to be concerned' over Trump's pharma tariffs

US Secretary of State Marco Rubio acknowledged India's concerns over President Donald Trump's proposed pharmaceutical tariffs.

Trump plans to impose steep tariffs on imported medicines, significantly affecting India's pharmaceutical exports to the US.

Rubio argued the tariffs aim to strengthen US domestic manufacturing and reduce dependence on overseas production for critical medicines.

He described pharmaceutical manufacturing as a strategic priority for US national security and supply chain resilience.

Rubio stated the US remains engaged with India despite the tariff policy.